Complete inhibition of mouse leukaemia L1210 by 5(or 4)-[3,3-bis(2-chloroethyl)-1-triazeno]imidazole-4(or 5)-carboxamide (NSC-82196).
D000230:Adenocarcinoma / Q000188:drug therapy; D000818:Animals; D002279:Carcinoma 256, Walker / Q000188:drug therapy; D007939:Leukemia L1210 / Q000188:drug therapy*; D051379:Mice; D009588:Nitrogen Mustard Compounds / Q000032:analysis; D051381:Rats; D012510:Sarcoma 180 / Q000188:drug therapy
D009588:Nitrogen Mustard Compounds